About this report
Measured figures come from published surveys, peer-reviewed studies and company reports, each with its date. Estimated figures are aikka calculations or third-party estimates with stated assumptions and ranges, and prospective statements on 2027 and 2030 are marked aikka view. The report is written for commercial, brand, medical affairs and market access leaders preparing their 2027 plans.
Aikka builds AI-native commercialization for pharma. PharmaGEO, its first product, measures how ChatGPT, Claude, Gemini, Perplexity, Mistral and Grok answer questions about medicines and the sources they use. Contact: request a call.
